Updates on the Management of Patients With Lymphomas During the COVID-19 Pandemic

Download this “living” slideset updated after ASH 2021 to gain an expert’s perspective on managing lymphomas during the COVID-19 pandemic, including key data on COVID-19 outcomes in this population, seroconversion after infection and vaccination, and implications of SARS-CoV-2 infection on cancer treatment.

John Allan, MD Released: February 3, 2022

Download this “living” slideset updated after ASH 2021 for an expert’s perspective on multidisciplinary care of patients with lymphomas during the COVID-19 pandemic, including strategies for addressing vaccine hesitancy, minimizing infection risk, and managing “long-haul” COVID-19.

Sandra E. Kurtin, PhD, ANP-C, AOCN Released: February 3, 2022